Page last updated: 2024-10-21

hydroxyindoleacetic acid and Prader-Willi Syndrome

hydroxyindoleacetic acid has been researched along with Prader-Willi Syndrome in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Prader-Willi Syndrome: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akefeldt, A1
Ekman, R1
Gillberg, C1
MÃ¥nsson, JE1

Other Studies

1 other study available for hydroxyindoleacetic acid and Prader-Willi Syndrome

ArticleYear
Cerebrospinal fluid monoamines in Prader-Willi syndrome.
    Biological psychiatry, 1998, Dec-15, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Age Factors; Autistic Disorder; Birth Weight; Body Mass Index; Child; Child, Pres

1998